In addition to some other inhibitory immune checkpoints in NK cells, such as NKG2A (see below), it seems that FN30/LILRB4 signaling can mitigate the cytotoxicity of NK cells and thus inhibit the elimination of cancer cells. Here, LILRB4 is linked to cancer.